Socio

Vinita Sithapathy

FUSIONES Y ADQUISICIONES, Private Equity, CORPORATIVO Y VALORES

Visión general

Corporate and private equity clients turn to Vinita Sithapathy for representation on domestic and cross-border M&A transactions. Vinita draws from over 10 years of experience to assist clients in a broad range of domestic and cross-border transactions, including mergers, acquisitions and sales of companies and businesses, consortium transactions, joint ventures, private investments, management rollovers, and reorganizations.

Experiencia

Represented

  • RWE Clean Energy in its joint venture with Peabody (NYSE: BTU) to strategically advance renewable energy projects by repurposing reclaimed land previously used for mining.
  • CDPQ in connection with Digital Bridge’s additional preferred equity investment in Vertical Bridge and related re-negotiation of joint venture arrangements between CDPQ and Digital Bridge, in connection with Vertical Bridge’s transaction with Verizon to lease, operate and manage 6,339 wireless communications towers across all 50 states and Washington DC from subsidiaries of Verizon for approximately $3.3 billion.
  • Google, in its: $5.4 billion acquisition of Mandiant, Inc. and related transactions with Blackstone and other private equity sponsors; $4.5 billion transaction with Jio Platforms, including investment and governance arrangements, and commercial; and agreements to develop an affordable smartphone with an optimized operating system.
  • Japan Tobacco, in its: acquisition of the Vector Group Ltd.; joint venture with the Altria Group to market and commercialize heated tobacco-stick products in the United States; $5 billion acquisition of the non-US operations of Natural American Spirit from Reynolds American; acquisition of Logic Technology, a leading US e-cigarette brand.
  • Cargill, in its joint venture with Continental Grain, in connection with the $4.3 billion acquisition of Sanderson Farms and Wayne Farms.
  • Novartis, in its: $5.4 billion sale of its animal health business to Eli Lilly; acquisitions of DTx Pharma and another preclinical-stage biotechnology company; tender offer to public shareholders of its Indian-listed subsidiary.
  • Kite Pharma, in its acquisition of Tmunity Therapeutics, a clinical-stage biotechnology company.
  • Basilea, in its acquisition of rights to a preclinical antifungal compound from Pfizer.
  • A sovereign wealth fund, in its consortium with private equity sponsors to acquire 50% of a $4.1 billion infrastructure company.

Servicios e Industrias Relacionadas

Educación

  • Columbia Law School, LLM
    Harlan Fiske Stone Scholar
  • University of Mumbai, BLS, LLB

Admisiones

  • Nueva York

Participación Profesional y Comunitaria

  • Co-creator and co-lecturer, Cross-Border M&A: Drafting, Negotiation & the Auction Process, Harvard Law School and Hebrew University, 2018-2019
Share